洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study

【ChiCTR2300073698】Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study

查看原文
立即下载
基本信息
登记号

ChiCTR2300073698

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2023-07-19

临床申请受理号

/

靶点

/

适应症

pilonidal sinus

试验通俗题目

Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study

试验专业题目

Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

The primary outcomes were duration of healing, post-operative morbidities, persistence of discharge and recurrence at 1-7 years (for cases enrolled in 2021 from 2015 respectively). The secondary outcomes were operative time, return to work, cosmetic results and patients satisfaction. Patients were observed for wound healing and discharge on follow up in OPD at 1, 3, 6 and 24 weeks. They were further followed up every year through telephonic survey for persistence or recurrence of symptoms. Patients satisfaction was assessed according to 36- Item Short Form Survey (SF-36) questionnaire filled at admission and then at 6 weeks after the surgery

试验分类
请登录查看
试验类型

单臂

试验分期

探索性研究/预试验

随机化

N/A

盲法

/

试验项目经费来源

nil

试验范围

/

目标入组人数

67

实际入组人数

/

第一例入组时间

2014-03-01

试验终止时间

2023-03-16

是否属于一致性

/

入选标准

All patients presenting to the Outpatients with pilonidal sinus with or without abscess will be included in the study；

排除标准

Only failure to give consent will be excluded；

研究者信息
研究负责人姓名
请登录查看
试验机构

Shifa international hospital

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Shifa international hospital的其他临床试验

更多

shifa college of medicine, shifa tameer e millat university islamabad的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品